| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.071 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |